AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
ANIMAL-MODEL OF LANCE-ADAMS-SYNDROME - TIME-COURSE AND NATURAL-HISTORY
Authors: PAPPERT EJ VU TQ GOETZ CG LEURGANS S RAMAN R
Citation: Ej. Pappert et al., ANIMAL-MODEL OF LANCE-ADAMS-SYNDROME - TIME-COURSE AND NATURAL-HISTORY, Annals of neurology, 44(3), 1998, pp. 46-46
POOR VISUAL-DISCRIMINATION AND VISUAL HALLUCINATIONS IN PARKINSONS-DISEASE
Authors: DIEDERICH NJ GOETZ CG RAMAN R PAPPERT EJ LEURGANS S PIERY V
Citation: Nj. Diederich et al., POOR VISUAL-DISCRIMINATION AND VISUAL HALLUCINATIONS IN PARKINSONS-DISEASE, Clinical neuropharmacology, 21(5), 1998, pp. 289-295
PHILADELPHIA-INFIRMARY-FOR-NERVOUS-DISEASES - AMERICA ORIGINAL MODEL OF INSTITUTIONAL NEUROLOGY
Authors: PAPPERT EJ
Citation: Ej. Pappert, PHILADELPHIA-INFIRMARY-FOR-NERVOUS-DISEASES - AMERICA ORIGINAL MODEL OF INSTITUTIONAL NEUROLOGY, Neurology, 50(6), 1998, pp. 1847-1853
19TH-CENTURY AMERICAN NEUROLOGICAL SOCIETIES
Authors: PAPPERT EJ
Citation: Ej. Pappert, 19TH-CENTURY AMERICAN NEUROLOGICAL SOCIETIES, Neurology, 50(4), 1998, pp. 2004-2004
LONGITUDINAL OBJECTIVE ASSESSMENT OF GILLES-DE-LA-TOURETTES-SYNDROME
Authors: PAPPERT EJ GOETZ CG LOUIS ED LEURGANS S RAMAN R BLASUCCI LM
Citation: Ej. Pappert et al., LONGITUDINAL OBJECTIVE ASSESSMENT OF GILLES-DE-LA-TOURETTES-SYNDROME, Neurology, 50(4), 1998, pp. 50005-50005
INTRAVENOUS LEVODOPA IN HALLUCINATING PARKINSONS-DISEASE PATIENTS - HIGH-DOSE CHALLENGE DOES NOT PRECIPITATE HALLUCINATIONS
Authors: GOETZ CG PAPPERT EJ BLASUCCI LM STEBBINS GT LING ZD NORA MV CARVEY PM
Citation: Cg. Goetz et al., INTRAVENOUS LEVODOPA IN HALLUCINATING PARKINSONS-DISEASE PATIENTS - HIGH-DOSE CHALLENGE DOES NOT PRECIPITATE HALLUCINATIONS, Neurology, 50(2), 1998, pp. 515-517
5-HYDROXYTRYPTOPHAN-INDUCED MYOCLONUS IN GUINEA-PIGS - MEDIATION THROUGH 5-HT1 2 RECEPTOR SUBTYPES/
Authors: PAPPERT EJ GOETZ CG STEBBINS GT BELDEN M CARVEY PM
Citation: Ej. Pappert et al., 5-HYDROXYTRYPTOPHAN-INDUCED MYOCLONUS IN GUINEA-PIGS - MEDIATION THROUGH 5-HT1 2 RECEPTOR SUBTYPES/, European journal of pharmacology, 347(1), 1998, pp. 51-56
PROGRESSIVE COGNITIVE DECLINE WITH TRUNCAL LIMB ATAXIA AND BALLISTIC MOVEMENTS/
Authors: KOMPOLITI K PAPPERT EJ GOETZ CG FORD B WOOD NW
Citation: K. Kompoliti et al., PROGRESSIVE COGNITIVE DECLINE WITH TRUNCAL LIMB ATAXIA AND BALLISTIC MOVEMENTS/, Movement disorders, 12(6), 1997, pp. 1075-1084
THE STABILITY OF CARBIDOPA IN SOLUTION
Authors: PAPPERT EJ LIPTON JW GOETZ CG LING ZD STEBBINS GT CARVEY PM
Citation: Ej. Pappert et al., THE STABILITY OF CARBIDOPA IN SOLUTION, Movement disorders, 12(4), 1997, pp. 608-610
STABILITY OF LEVODOPA CARBIDOPA SOLUTIONS - REPLY/
Authors: PAPPERT EJ GOETZ CG LIPTON JW LING ZD STEBBINS GT CARVEY PM
Citation: Ej. Pappert et al., STABILITY OF LEVODOPA CARBIDOPA SOLUTIONS - REPLY/, Movement disorders, 12(4), 1997, pp. 625-625
EFFECTS OF SPECIFIC SEROTONERGIC ANTAGONISTS ON THE RAT CARDIAC-ARREST MODEL OF POSTHYPOXIC MYOCLONUS
Authors: PAPPERT EJ GOETZ CG LING ZD RAMAN R LEURGANS S CARVEY PM
Citation: Ej. Pappert et al., EFFECTS OF SPECIFIC SEROTONERGIC ANTAGONISTS ON THE RAT CARDIAC-ARREST MODEL OF POSTHYPOXIC MYOCLONUS, Annals of neurology, 42(3), 1997, pp. 63-63
EARLY AMERICAN PROFESSORSHIPS IN NEUROLOGY - REPLY
Authors: GOETZ CG PAPPERT EJ
Citation: Cg. Goetz et Ej. Pappert, EARLY AMERICAN PROFESSORSHIPS IN NEUROLOGY - REPLY, Annals of neurology, 41(3), 1997, pp. 417-417
PRIMARY DEFICITS IN VISUAL-DISCRIMINATION IS A RISK FACTOR FOR VISUALHALLUCINATIONS IN PARKINSONS-DISEASE
Authors: DIEDERICH NJ GOETZ CG RAMAN R PAPPERT EJ
Citation: Nj. Diederich et al., PRIMARY DEFICITS IN VISUAL-DISCRIMINATION IS A RISK FACTOR FOR VISUALHALLUCINATIONS IN PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 3092-3092
EARLY AMERICAN NEUROLOGICAL JOURNALS
Authors: PAPPERT EJ
Citation: Ej. Pappert, EARLY AMERICAN NEUROLOGICAL JOURNALS, Neurology, 48(3), 1997, pp. 36002-36002
INTRAVENOUS LEVODOPA INFUSIONS IN SEVERELY HALLUCINATING PARKINSONS-DISEASE PATIENTS - HIGH-DOSE PHARMACOLOGICAL CHALLENGE DOES NOT PRECIPITATE HALLUCINATIONS
Authors: GOETZ CG PAPPERT EJ BLASUCCI LM STEBBINS GT LING ZD NORA MV CARVEY PM
Citation: Cg. Goetz et al., INTRAVENOUS LEVODOPA INFUSIONS IN SEVERELY HALLUCINATING PARKINSONS-DISEASE PATIENTS - HIGH-DOSE PHARMACOLOGICAL CHALLENGE DOES NOT PRECIPITATE HALLUCINATIONS, Neurology, 48(3), 1997, pp. 60005-60005
LEVODOPA STABILITY IN SOLUTION - TIME-COURSE, ENVIRONMENTAL-EFFECTS, AND PRACTICAL RECOMMENDATIONS FOR CLINICAL USE
Authors: PAPPERT EJ BUHRFIEND C LIPTON JW CARVEY PM STEBBINS GT GOETZ CG
Citation: Ej. Pappert et al., LEVODOPA STABILITY IN SOLUTION - TIME-COURSE, ENVIRONMENTAL-EFFECTS, AND PRACTICAL RECOMMENDATIONS FOR CLINICAL USE, Movement disorders, 11(1), 1996, pp. 24-26
5-HTP-INDUCED MYOCLONUS IS SPECIFICALLY MEDIATED THROUGH THE 5-HT1 SUBSYSTEM - IMPLICATIONS FOR NEW DRUG DEVELOPMENT
Authors: PAPPERT EJ BELDEN M STEBBINS GT GOETZ CG CARVEY PM
Citation: Ej. Pappert et al., 5-HTP-INDUCED MYOCLONUS IS SPECIFICALLY MEDIATED THROUGH THE 5-HT1 SUBSYSTEM - IMPLICATIONS FOR NEW DRUG DEVELOPMENT, Annals of neurology, 40(3), 1996, pp. 172-172
EARLY AMERICAN PROFESSORSHIPS IN NEUROLOGY
Authors: GOETZ CG PAPPERT EJ
Citation: Cg. Goetz et Ej. Pappert, EARLY AMERICAN PROFESSORSHIPS IN NEUROLOGY, Annals of neurology, 40(2), 1996, pp. 258-263
LIQUID LEVODOPA CARBIDOPA PRODUCES SIGNIFICANT IMPROVEMENT IN MOTOR FUNCTION WITHOUT DYSKINESIA EXACERBATION/
Authors: PAPPERT EJ GOETZ CG NIEDERMAN F LING ZD STEBBINS GT CARVEY PM
Citation: Ej. Pappert et al., LIQUID LEVODOPA CARBIDOPA PRODUCES SIGNIFICANT IMPROVEMENT IN MOTOR FUNCTION WITHOUT DYSKINESIA EXACERBATION/, Neurology, 47(6), 1996, pp. 1493-1495
ALPHA-TOCOPHEROL IN THE VENTRICULAR CEREBROSPINAL-FLUID OF PARKINSONS-DISEASE PATIENTS - DOSE-RESPONSE STUDY AND CORRELATIONS WITH PLASMA-LEVELS
Authors: PAPPERT EJ TANGNEY CC GOETZ CG LING ZD LIPTON JW STEBBINS GT CARVEY PM
Citation: Ej. Pappert et al., ALPHA-TOCOPHEROL IN THE VENTRICULAR CEREBROSPINAL-FLUID OF PARKINSONS-DISEASE PATIENTS - DOSE-RESPONSE STUDY AND CORRELATIONS WITH PLASMA-LEVELS, Neurology, 47(4), 1996, pp. 1037-1042
THE OPEDIC-HOSPITAL-AND-INFIRMARY-FOR-NERVOUS-DISEASES - AMERICA ORIGINAL INSTITUTIONAL MODEL OF NEUROLOGICAL STUDY
Authors: PAPPERT EJ
Citation: Ej. Pappert, THE OPEDIC-HOSPITAL-AND-INFIRMARY-FOR-NERVOUS-DISEASES - AMERICA ORIGINAL INSTITUTIONAL MODEL OF NEUROLOGICAL STUDY, Neurology, 46(2), 1996, pp. 56004-56004
LIQUID LEVODOPA CARBIDOPA PRODUCES SIGNIFICANT IMPROVEMENT IN MOTOR FUNCTION WITHOUT DYSKINESIA EXACERBATION/
Authors: PAPPERT EJ GOETZ CG NIEDERMAN FG STEBBINS GT CHMURA TA
Citation: Ej. Pappert et al., LIQUID LEVODOPA CARBIDOPA PRODUCES SIGNIFICANT IMPROVEMENT IN MOTOR FUNCTION WITHOUT DYSKINESIA EXACERBATION/, Annals of neurology, 38(2), 1995, pp. 298-299
TRAINING OPPORTUNITIES FOR THE 19TH-CENTURY AMERICAN NEUROLOGIST - PRELUDES TO THE MODERN NEUROLOGY RESIDENCY
Authors: PAPPERT EJ
Citation: Ej. Pappert, TRAINING OPPORTUNITIES FOR THE 19TH-CENTURY AMERICAN NEUROLOGIST - PRELUDES TO THE MODERN NEUROLOGY RESIDENCY, Neurology, 45(9), 1995, pp. 1771-1776
EARLY AMERICAN NEUROLOGIC TEXTBOOKS
Authors: PAPPERT EJ GOETZ CG
Citation: Ej. Pappert et Cg. Goetz, EARLY AMERICAN NEUROLOGIC TEXTBOOKS, Neurology, 45(6), 1995, pp. 1228-1232
INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN
Authors: AMATO AA BAROHN RJ JACKSON CE PAPPERT EJ SAHENK Z KISSEL JT
Citation: Aa. Amato et al., INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN, Neurology, 44(8), 1994, pp. 1516-1518
Risultati: 1-25 | 26-26